← Eichor
Study identifier: NCT07251049 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing

Condition: Acute Encephalitis · Acute Myelitis  ·  Sponsor: Centre Hospitalier Universitaire de la Guadeloupe

PhaseN/A
Planned participants100
Who can joinAll sexes, 28 Days to no upper limit
Healthy volunteersNo

About this study

: Encephalitis or myelitis is defined as the inflammatory or infectious involvement of the cerebral parenchyma or spinal cord. When an infectious origin is suspected, the germ is not always identified. Next-generation sequencing could be used to correct an etiological diagnosis of these severe conditions in Guadeloupe. The rate of cases for which the infectious agent is not identified encourages continued diagnostic efforts, with the objective of identifying new pathogens or emerging pathogens, some of which may be more specific in the tropics.

This description comes directly from the study's public registry record.

Talk to the study team

Val"érie HAMONY-SOTER  ·  +590 590 93 46 77  ·  valerie.soter@chu-guadeloupe.fr

Eunice NUBRET  ·  0590934686  ·  eunice.nubret@chu-guadeloupe.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Centre Hospitalier Universitaire de la GuadeloupePointe-à-Pitre, Guadeloupe, GuadeloupeRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07251049